【摘 要】
：
Gastrointestinal (GI) cancers are the most common human malignancies in the world.Surgical resection continues being the primary curative treatment for most of them.
【机 构】
：
Oncology Department Royal Bournemouth Hospital NHS Foundation Trust UK
论文部分内容阅读
Gastrointestinal (GI) cancers are the most common human malignancies in the world.Surgical resection continues being the primary curative treatment for most of them.
其他文献
Paragangliomas are relatively rare chromaffin cell tumors which may be cured through resection.Patients with paragangliomas may develop metastatic diseases.
Breast cancer is one of the major killers among malignant conditions worldwide,affecting one,out of 10 women in industrialized countries,and being the leading cause of cancer-related morbidity and mor
Extended adjuvant endocrine therapy (10 vs.5 years) trials have demonstrated improved outcomes in early-stage estrogen receptor (ER)-positive breast cancer;however,the absolute benefit is modest,and t
Breast cancer is the most common cancer in women worldwide and second leading cause of deaths among women in the United States.
Metastatic breast cancer is considered an incurable disease,and the main treatment goal is palliation,with the aim of maintaining or improving the quality of life and possibly improving survival.
Oncolytic virus therapy (OVs) has recently emerged as a promising antitumor therapeutics mainly due to selectively replicate in tumor cells while sparing normal cells.
We analyzed the outcome of immunotherapy in the additional adjuvant treatment of rectal cancer with dendritic cell therapy.Patients (n=71) who underwent curative surgery for rectal cancer were include
Metabolic transformation is a cardinal hallmark of most cancer cells that increases their proliferative and anti-apoptotic capacity by boosting anabolic metabolism,mainly through aerobic glycolysis an
Cancer Therapeutics exploits the subtle differences one can find between cancer and normal cells to fight off cancer.These differences can be present on their cell surfaces,and such biomarkers can be
Alpha-Enolase (ENO 1) is a catalytic enzyme participating in the penultimate step of glycolysis and also poses several non-metabolic functions such as plasminogen-binding.